FIELD: medicine. SUBSTANCE: method involves administering 2,4-dioxo-5-fluoropyrimidine (fluorouracyl) at a daily dose of 1-2 mg/kg daily. EFFECT: enhanced effectiveness of treatment. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING THE CASES OF TUBERCULOSIS | 2002 |
|
RU2212240C1 |
| METHOD OF TREATMENT OF EXPERIMENTAL TUBERCULOSIS | 2001 |
|
RU2207127C1 |
| ANTI-TUBERCULOSIS PREPARATION | 2002 |
|
RU2211035C1 |
| METHOD FOR TREATING TUBERCULOSIS | 2004 |
|
RU2269346C1 |
| TUBERCULOSTAT AGENT | 2001 |
|
RU2185170C1 |
| METHOD FOR TREATING ACUTE MILIARY PULMONARY TUBERCULOSIS | 1999 |
|
RU2188034C2 |
| METHOD OF STIMULATION OF IMMUNOBIOLOGICAL RESISTANCE | 1996 |
|
RU2148995C1 |
| TUBERCULOSTATIC AGENT | 2002 |
|
RU2207126C1 |
| DRUG PREPARATION FOR TREATING TUBERCULOSIS | 2013 |
|
RU2523792C9 |
| METHOD OF TREATING PULMONARY TUBERCULOSIS FEATURING PREDOMINANTLY EXUDATIVE TYPE OF INFLAMMATION | 1990 |
|
RU2008902C1 |
Authors
Dates
2001-04-27—Published
2000-06-05—Filed